Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in PBYI — Puma Biotechnology, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$350,287
+$138,491 QoQ
Shares Held
43,192
+30.3% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 160 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. PBYI ranks #201 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in PBYI

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $350,287 43,192
2026-03-31 $211,796 33,145
2025-09-30 $163,245 30,743
2025-06-30 $105,448 30,743
2025-03-31 $90,999 30,743
2022-03-31 $53,210 18,476
2021-12-31 $62,483 20,554
2021-09-30 $144,488 20,612
2021-06-30 $303,425 33,053
2021-03-31 $254,488 26,182
2020-12-31 $287,842 28,055
2020-09-30 $3,756,071 372,257
2020-06-30 $6,710,003 643,337
2020-03-31 $4,608,728 546,058